Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Biotin may benefit patients with IBD

Publish date:: April 10, 2020

Key clinical point: Biotin supplementation may have therapeutic potential for patients with inflammatory bowel disease (IBD).

Major finding: In mice, biotin supplementation delayed onset of colitis, minimized pathology, and accelerated healing.

Study details: An inflammatory bowel disease mouse model study.

Disclosures: The study was funded by the Veteran’s Administration and the National Institutes of Health. The investigators reported no conflicts of interest.

Citation:

Skupsky J et al. Cell Mol Gastroenterol Hepatol. 2019 Nov 28. doi: 10.1016/j.jcmgh.2019.11.011.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Endoscopic intragastric balloon improved NASH parameters,

Autologous fecal microbiota transplantation helped maintain weight loss after ‘green’ Mediterranean diet,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,

Must Reads in IBD & Intestinal Disorders

Normal gut colonizer induces serotonergic system, appears to regulate behavior,

IL-23 plays key roles in antimicrobial macrophage activity,

Diarrhea prevalent among COVID-19 patients with IBD,

Complete endoscopic healing tied to better Crohn’s disease outcomes,

Studies eyes risks for poor outcomes in primary sclerosing cholangitis,